321 filings
Page 3 of 17
6-K
unjiejs
11 May 22
BELLUS Health Reports First Quarter 2022 Financial Results and Business Highlights
5:23pm
6-K
np1qwnh oxt34zu9f7
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
b8ewkr8kvhlo8h2pp
2 May 22
BELLUS Health to Present Late-Breaking Clinical Data from the Phase 2b SOOTHE Trial of BLU-5937 at the ATS 2022 International Conference
7:00am
6-K
cs32k4t5
25 Apr 22
BELLUS Health to Participate in Multiple Upcoming Investor Conferences
4:02pm
6-K
1tyfk9nzq tm
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
5thr2 tvi20v
5 Apr 22
Current report (foreign)
4:07pm
6-K
gf01bw4dit
4 Mar 22
Report of Foreign Private Issuer for the Month of March 2022
11:32am
6-K
ok2jh08q5cvem1c0k
1 Mar 22
BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference
7:00am
6-K
09uj4a 9rsgau
23 Feb 22
BELLUS Health Reports Year 2021 Financial Results and Business Highlights
4:01pm
6-K
e1hfua7j
17 Dec 21
BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States
4:03pm
6-K
iiqnvu
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
6-K
bvx4jd6qf 20wrut8trs
13 Dec 21
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
4:07pm
6-K
oaaz3q
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
qgklkq2
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
zq8vokhdqkuzxd1wz7
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
6-K
sq5yz
10 Nov 21
BELLUS Health Reports Third Quarter 2021 Financial Results and Business Highlights
4:30pm
6-K
v41g5 1kug8cqrb1s15
10 Nov 21
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
7:00am
6-K
7plfg 6qh7919
1 Nov 21
Bellus Health Inc. 6-K
7:00am
6-K
x9n50wo1 qrtq9u
23 Sep 21
Topline results from both studies are expected in December 2021
7:00am
6-K
yqz78z1c 97o1
13 Sep 21
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough
7:45am